MLEC News & Events

Moolec Science announced the completion of the 2026 commercial planting campaign for its GLASO safflower program focused on the production of high-GLA specialty oils for industrial and advanced ingredient applications. "Today represents a defining moment for Moolec. Regaining compliance with Nasdaq while simultaneously advancing the commercial execution of our GLASO platform reflects the extraordinary resilience, discipline, and commitment of our entire team. Over the past quarters, we have worked relentlessly across operations, finance, science, and corporate execution to strengthen the foundations of the Company for the long term. The successful execution of our 2026 commercial planting campaign, together with the continued advancement of our proprietary genetics platform, demonstrates our ability to keep building and executing even during challenging periods. We are also extremely proud of the professionalism and dedication demonstrated by our farming partners in the United States, whose operational expertise and execution capabilities are playing an important role in the continued development of the GLASO platform. We believe the progress achieved across our operational and corporate initiatives positions Moolec for the next phase of scalable commercialization and growth," commented Alejandro Antalich, Chief Executive Officer of Moolec Science. Commercial planting activities commenced on May 4, 2026, and were successfully completed this week during the optimal agronomic planting window in the American Falls region of Idaho, an area recognized for its favorable conditions for safflower cultivation, including a semi-arid climate, low-humidity environment, well-drained soils, strong solar exposure, and access to established irrigation infrastructure. The 2026 campaign represents another important operational milestone as GLASO continues progressing toward larger-scale commercial execution supported by proprietary genetics, advanced agronomic management, and increasing demand for differentiated specialty oil solutions. All production fields were planted following extensive soil preparation, irrigation optimization, and seed conditioning protocols designed to maximize germination performance, crop emergence, and stand establishment. Based on current field conditions and forecasted temperatures, the Company expects strong crop establishment during the coming weeks.

Moolec Science, a subsidiary of Moolec Science, announced the successful completion of the first phase of industrialization of its GLASO1 safflower platform, following a 2025 campaign that materially exceeded all internal forecasts. Building on previously reported results confirming approximately 45% GLA concentration at commercial scale, the Company has now validated not only agronomic and processing performance, but also the industrial-scale handling and availability of high-purity GLA output.

Moolec Science, a wholly owned subsidiary of Moolec Science SA, announced a significant scientific breakthrough in the production of animal proteins in plants. Through a sponsored research project with one of the most prestigious academic institutions in the United States of America, Moolec has successfully demonstrated the stable expression of bovine myoglobin, a heme-containing protein, within the seeds of the common pea. This 28-month research project represents the first reported case of producing bovine myoglobin in pea seeds, marking a significant expansion of Moolec's molecular farming platform beyond its current crop base.